> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest Federal Register Notices
- URL: https://www.fdaweb.com/latest-federal-register-notices-7/
- Published: 2020-01-05T12:00:00.000Z
- Updated: 2026-09-14T15:57:17.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5145771

[**Patient Engagement Panel Renewed for 2 Years**](https://www.fdaweb.com/login.php?sa=v&aid=D5145763&cate=FR&stid=%241%24M0%2F.l1%2F.%24TnBHYMfxKO4CvzVvk8E.40)  
*Federal Register* notice: FDA renews for two years the charter for its Patient Engagement Advisory Committee. 01/06/2020  

[**Pharmaceutical Science Panel Charter Renewal**](https://www.fdaweb.com/login.php?sa=v&aid=D5145764&cate=FR&stid=%241%24M0%2F.l1%2F.%24TnBHYMfxKO4CvzVvk8E.40)  
*Federal Register* notice: FDA has renewed for another two years the charter for its Pharmaceutical Science and Clinical Pharmacology Advisory Committee. 01/06/2020  

[**Info Collection Extension for Panel Nominations**](https://www.fdaweb.com/login.php?sa=v&aid=D5145768&cate=FR&stid=%241%24M0%2F.l1%2F.%24TnBHYMfxKO4CvzVvk8E.40)  
*Federal Register* notice: FDA seeks comments on an information collection extension for its Advisory Committee Membership Nominations. 01/06/2020  

[**Info Collection Extension on Special Protocols**](https://www.fdaweb.com/info-collection-extension-on-special-protocols/)  
*Federal Register* notice: FDA seeks comments on an information collection extension for its guidance on “Special Protocol Assessment.” 01/03/2020  

[**Info Collection on Electronic Imports Revised**](https://www.fdaweb.com/info-collection-on-electronic-imports-revised/)  
*Federal Register* notice: FDA seeks comments on an information collection revision for “Imports and Electronic Import Entries.” 01/03/2020  

[**Input Sought on FDA Minority Health Priorities**](https://www.fdaweb.com/input-sought-on-fda-minority-health-priorities/)  
*Federal Register* notice: FDA seeks input and comments from interested stakeholders to help it establish strategic priorities for its Office of Minority Health and Health Equity. 01/02/2020